4523.T实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 14:15):

Stats
今日成交量	995 400
平均成交量	1.43M
市值	1 878.65B
EPS	¥0 ( 2024-02-05 )
下一个收益日期	( ¥41.14 ) 2024-05-13
Last Dividend	¥80.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	41.30
ATR14	¥2.30 (0.04%)

音量相关性

長: 0.05 (neutral)

短: -0.38 (neutral)

Signal:(42.108) Neutral

Eisai Co., Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Eisai Co., Ltd. 相关性 - 货币/商品

-0.54
( weak negative )

-0.65
( moderate negative )

-0.34
( neutral )

-0.49
( neutral )

0.53
( weak )

0.68
( moderate )

Eisai Co., Ltd. 财务报表

Annual	2022
营收:	¥744.40B
毛利润:	¥566.57B (76.11 %)
EPS:	¥193.31

FY	2022
营收:	¥744.40B
毛利润:	¥566.57B (76.11 %)
EPS:	¥193.31

FY	2022
营收:	¥756.23B
毛利润:	¥581.40B (76.88 %)
EPS:	¥669.08

FY	2021
营收:	¥645.94B
毛利润:	¥484.63B (75.03 %)
EPS:	¥146.95

Financial Reports:

No articles found.

Eisai Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥80.00 (N/A)	¥0 (N/A)	¥80.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Eisai Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.47 - Stable (9.38%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥11.50	2000-03-28
Last Dividend	¥80.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	48	--
Total Paid Out	¥2 807.50	--
Avg. Dividend % Per Year	0.00%	--
Score	3.8	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.47
Div. Directional Score	7.74	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

3.80

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8242.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7609.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
6807.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6151.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4887.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
4062.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3282.T	Ex Dividend Junior	2024-01-30	Semi-Annually	0.00%
2325.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
9267.T	Ex Dividend Knight	2023-12-19	Semi-Annually	0.00%
8014.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0606	1.500	8.79	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0346	1.200	8.85	10.00	[0 - 0.3]
returnOnEquityTTM	0.0546	1.500	-0.504	-0.756	[0.1 - 1]
payoutRatioTTM	1.011	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	2.38	0.800	3.10	2.48	[1 - 3]
quickRatioTTM	1.697	0.800	4.72	3.78	[0.8 - 2.5]
cashRatioTTM	1.025	1.500	5.42	8.12	[0.2 - 2]
debtRatioTTM	0.127	-1.500	7.89	-10.00	[0 - 0.6]
interestCoverageTTM	27.29	1.000	1.003	1.003	[3 - 30]
operatingCashFlowPerShareTTM	215.91	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	124.48	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.203	-1.500	9.19	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.789	1.000	0.176	0.176	[0.2 - 0.8]
operatingProfitMarginTTM	0.0851	1.000	-0.299	-0.299	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.372	1.000	9.04	9.04	[0.2 - 2]
assetTurnoverTTM	0.572	0.800	9.52	7.62	[0.5 - 2]
Total Score				10.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	41.26	1.000	5.93	0	[1 - 100]
returnOnEquityTTM	0.0546	2.50	-0.324	-0.756	[0.1 - 1.5]
freeCashFlowPerShareTTM	124.48	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.45	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	215.91	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	1.011	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	2.98	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0826	1.000	-0.434	0	[0.1 - 0.5]
Total Score				5.47

Eisai Co., Ltd.

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.